Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy (Q44470806)

3 December 2017

title

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy (English)

1 reference

Adaptive radiation therapy

3 December 2017

main subject

0 references

author name string

Garg MK

1

1 reference

3 December 2017

Tekyi-Mensah S

2

1 reference

3 December 2017

Bolton S

3

1 reference

3 December 2017

Velasco J

4

1 reference

3 December 2017

Pontes E

5

1 reference

3 December 2017

Wood DP Jr

6

1 reference

3 December 2017

Porter AT

7

1 reference

3 December 2017

Forman JD

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

3 December 2017

1 reference

3 December 2017

volume

51

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

998-1002

1 reference

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Serum prostate-specific antigen after post-prostatectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900023-5

7 January 2021

10.1016/S0090-4295(98)00023-5

Identifiers

DOI

1 reference

3 December 2017

1 reference